Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention

Key Points

• The aim is to evaluate the clinical use of C-reactive protein in detecting and preventing cardiovascular disease.
• Evaluated C-reactive protein levels in a randomized trial setting
• Assessed cardiovascular disease risk in participants based on biomarker data
• Implemented preventive strategies based on C-reactive protein assessment
• Higher C-reactive protein levels correlated with increased cardiovascular disease risk
• Interventions led to a significant reduction in cardiovascular events in participants with elevated C-reactive protein
• Improvement in risk assessment accuracy using C-reactive protein as a biomarker